The LifeStent self-expanding nitinol stent is a percutaneously-delivered flexible mesh tube that expands when deployed to prop open a diseased vessel and is specifically designed to withstand bending
As per the agreement, the combined expertise of the two companies creates a highly efficient product flow from API manufacturing through regulatory approval and distribution that will bring
Mr Sidransky is a renowned oncologist and research scientist named and profiled by TIME magazine in 2001 as one of the top physicians and scientists in America, recognized
Under the terms of the agreement, Asuragen will receive an undisclosed payment for the development of the test that is expected to be completed in 2008. Upon completion
Cleviprex is a novel investigational IV antihypertensive for the treatment of acute hypertension when the use of oral therapy is not feasible or desirable. Among patients treated in
In the study, trodusquemine was found to be well-tolerated at likely clinical doses, and no serious adverse events were seen in healthy overweight and obese adults. Study MSI-1436C-101,
Consistent with the anti-VEGFR activity of XL184, preliminary pharmacodynamic analyses show reductions in several biomarkers of angiogenesis. Anti-tumor activity has been observed in a variety of cancers at
Hana Biosciences’ data has demonstrated anti-tumor activity in three of eleven patients with refractory solid tumors and has also showed that Alocrest was relatively well tolerated over multiple
Cholestagel is aimed at treating patients with primary hypercholesterolemia who cannot meet their targeted cholesterol levels with standard therapies alone. Cholestagel is a polymer in tablet form that
The board of directors also announced its intention to explore strategic alternatives with respect to its generics business. Completion of the proposed spin-off is subject to numerous conditions,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.